{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:18:19Z","timestamp":1790821099205,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to investigate the factors influencing the cure, recurrence, and metastasis rates of stage IA lung adenocarcinoma, using a mixed cure model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,064 patients who underwent video-assisted thoracoscopic pulmonectomy were included. Variable screening was performed using the random forest algorithm and least absolute shrinkage and selection operator approaches. The mixed cure model was used to identify factors affecting patient cure and survival, and a sequential analysis was performed on 5%, 10%, and 20% of the presentational subtype concurrently. A receiver operating characteristics curve was used to determine the best model and construct a nomogram to predict the cure rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median follow-up time was 58 (range: 3\u2013115) months. Results from the cure part of the mixed model indicated that the predominant subtype, presentational subtype, and tumor diameter were the main prognostic factors affecting cure rate. Therefore, the nomogram to predict the cure rate was constructed based on these factors. The survival part indicated that the predominant subtype was the only factor that influenced recurrence and metastasis. A sequential analysis of the presentational subtype showed it had no significant effect on survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Regardless of the recording mode, no significant improvement was observed in the model's discriminative ability. Only a few postoperative pathological specimens showed lymphovascular invasion (LVI); however, the survival curve suggested a significant effect on patient survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After excluding the existence of long-term survivors, the predominant tumor subtype was determined to be the only factor influencing recurrence and metastasis. Although LVI is rare in stage IA lung adenocarcinoma, its significance cannot be discounted in terms of determining patient prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02725-9","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:01:51Z","timestamp":1698757311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhixin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinghang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"issue":"3","key":"2725_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660. PMID 33538338.","journal-title":"CA Cancer J Clin"},{"issue":"10335","key":"2725_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","volume":"399","author":"H Saji","year":"2022","unstructured":"Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(21)02333-3. PMID 35461558.","journal-title":"Lancet"},{"key":"2725_CR3","doi-asserted-by":"publisher","unstructured":"Suzuki K, Watanabe S, Wakabayashi M, Moriya Y, Yoshino I, Tsuboi M, et al. A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography (JCOG0804\/WJOG4507L). J Clin Oncol. 2017;35(15_suppl):8561.\u00a0\u00a0https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.8561.","DOI":"10.1200\/JCO.2017.35.15_suppl.8561"},{"issue":"6","key":"2725_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S2213-2600(23)00041-3","volume":"11","author":"K Aokage","year":"2023","unstructured":"Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, et al. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. 2023;11(6):540\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(23)00041-3. PMID 36893780.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2725_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1148\/radiol.2021210109","volume":"302","author":"T Wang","year":"2022","unstructured":"Wang T, She Y, Yang Y, Liu X, Chen S, Zhong Y, et al. Radiomics for survival risk stratification of clinical and pathologic stage IA Pure-Solid non-small cell lung cancer. Radiology. 2022;302(2):425\u201334. https:\/\/doi.org\/10.1148\/radiol.2021210109. PMID 34726531.","journal-title":"Radiology"},{"issue":"2","key":"2725_CR6","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/j.cllc.2020.09.0123","volume":"22","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Mao Y, He J, Gao S, Zhang Z, Ding N, et al. Lobe-specific lymph node dissection in clinical stage IA solid-dominant non-small-cell lung cancer: A propensity score matching study. Clin Lung Cancer. 2021;22(2):e201\u201310. https:\/\/doi.org\/10.1016\/j.cllc.2020.09.0123. PMID 33187913.","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"2725_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/ejcts\/ezaa369","volume":"59","author":"TZ Abughararah","year":"2021","unstructured":"Abughararah TZ, Jeong YH, Alabbood F, Chong Y, Yun JK, Lee GD, et al. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study. Eur J Cardiothorac Surg. 2021;59(4):783\u201390. https:\/\/doi.org\/10.1093\/ejcts\/ezaa369. PMID 33150427.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"2725_CR8","doi-asserted-by":"publisher","first-page":"e2131892","DOI":"10.1001\/jamanetworkopen.2021.31892","volume":"4","author":"SPL Saw","year":"2021","unstructured":"Saw SPL, Zhou S, Chen J, Lai G, Ang MK, Chua K, et al. Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor-positive non-small cell lung cancer. JAMA Netw Open. 2021;4(11):e2131892. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.31892,\u00a0\u00a0PMID 34739062.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2725_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jtho.2016.07.023","volume":"11","author":"W Xu","year":"2016","unstructured":"Xu W, Jia G, Davie JR, Murphy L, Kratzke R, Banerji S. A 10-gene Yin Yang expression ratio signature for stage IA and IB non-small cell lung cancer. J Thorac Oncol. 2016;11(12):2150\u201360. https:\/\/doi.org\/10.1016\/j.jtho.2016.07.023. PMID 27498386.","journal-title":"J Thorac Oncol"},{"key":"2725_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3389\/fonc.2019.01385","volume":"9","author":"Y Wo","year":"2019","unstructured":"Wo Y, Yang H, Zhang Y, Wo J. Development and external validation of a nomogram for predicting survival in patients with stage IA non-small cell lung cancer \u22642 cm undergoing sublobectomy. Front Oncol. 2019;9:1385. https:\/\/doi.org\/10.3389\/fonc.2019.01385. PMID 31921643.","journal-title":"Front Oncol"},{"issue":"4","key":"2725_CR11","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1016\/j.cllc.2020.10.009","volume":"22","author":"RE Merritt","year":"2021","unstructured":"Merritt RE, Abdel-Rasoul M, Fitzgerald M, D\u2019Souza DM, Kneuertz PJ. Nomograms for predicting overall and recurrence-free survival from pathologic stage IA and IB lung cancer after lobectomy. Clin Lung Cancer. 2021;22(4):e574\u201383. https:\/\/doi.org\/10.1016\/j.cllc.2020.10.009. PMID 33234491.","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"2725_CR12","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.asjsur.2022.01.010","volume":"45","author":"Z Huang","year":"2022","unstructured":"Huang Z, Peng K, Hong Z, Zhang P, Kang M. Nomogram for predicting recurrence and metastasis of stage IA lung adenocarcinoma treated by video-assisted thoracoscopic surgery lobectomy. Asian J Surg. 2022;45(12):2691\u20139. https:\/\/doi.org\/10.1016\/j.asjsur.2022.01.010. PMID 35153141.","journal-title":"Asian J Surg"},{"issue":"7","key":"2725_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ijc.27802","volume":"132","author":"M Cvancarova","year":"2013","unstructured":"Cvancarova M, Aagnes B, Foss\u00e5 SD, Lambert PC, M\u00f8ller B, Bray F. Proportion cured models applied to 23 cancer sites in Norway. Int J Cancer. 2013;132(7):1700\u201310. https:\/\/doi.org\/10.1002\/ijc.27802. PMID 22927104.","journal-title":"Int J Cancer"},{"issue":"4","key":"2725_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jval.2016.04.011","volume":"20","author":"M Othus","year":"2017","unstructured":"Othus M, Bansal A, Koepl L, Wagner S, Ramsey S. Accounting for cured patients in cost-effectiveness analysis. Value Health. 2017;20(4):705\u20139. https:\/\/doi.org\/10.1016\/j.jval.2016.04.011. PMID 28408015.","journal-title":"Value Health"},{"issue":"1","key":"2725_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10489-021-02311-8","volume":"52","author":"M Pedrosa-Laza","year":"2022","unstructured":"Pedrosa-Laza M, L\u00f3pez-Cheda A, Cao R. Cure models to estimate time until hospitalization due to COVID-19: A case study in Galicia (NW Spain). Appl Intell (Dordr). 2022;52(1):794\u2013807. https:\/\/doi.org\/10.1007\/s10489-021-02311-8. PMID 34764600.","journal-title":"Appl Intell (Dordr)"},{"issue":"3","key":"2725_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/biostatistics\/kxy011","volume":"20","author":"LJ Beesley","year":"2019","unstructured":"Beesley LJ, Taylor JMG. EM algorithms for fitting multistate cure models. Biostatistics. 2019;20(3):416\u201332. https:\/\/doi.org\/10.1093\/biostatistics\/kxy011. PMID 29584820.","journal-title":"Biostatistics"},{"issue":"21","key":"2725_CR17","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713. PMID 15534099.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2725_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.2517-6161.1949.tb00020.x","volume":"11","author":"JW Boag","year":"1948","unstructured":"Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc B (Methodol). 1948;11(1):15\u201344.","journal-title":"J R Stat Soc B (Methodol)"},{"issue":"259","key":"2725_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/01621459.1952.10501187","volume":"47","author":"J Berkson","year":"1952","unstructured":"Berkson J, Gage RP. Survival curve for cancer patients following treatment. J Am Stat Assoc. 1952;47(259):501\u201315. https:\/\/doi.org\/10.1080\/01621459.1952.10501187.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2725_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13019-020-01199-8","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Hu Z, Zhao J, Huang Y, Rao S, Yang J, et al. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis. J Cardiothorac Surg. 2020;15(1):154. https:\/\/doi.org\/10.1186\/s13019-020-01199-8. PMID 32600473.","journal-title":"J Cardiothorac Surg"},{"issue":"4","key":"2725_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00432-017-2571-7","volume":"144","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Ma G, Zhang Y, Chen H. Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis. J Cancer Res Clin Oncol. 2018;144(4):743\u20139. https:\/\/doi.org\/10.1007\/s00432-017-2571-7. PMID 29392402.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"2725_CR22","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1245\/s10434-015-5043-9","volume":"23","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Wang R, Shen X, Pan Y, Cheng C, Li Y, et al. Minor components of micropapillary and solid subtypes in lung adenocarcinoma are predictors of lymph node metastasis and poor prognosis. Ann Surg Oncol. 2016;23(6):2099\u2013105. https:\/\/doi.org\/10.1245\/s10434-015-5043-9. PMID 26842488.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2725_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira AL, Ocampo PSS, Xia Y, Zhong H, Russell PA, Minami Y, et al. A grading system for invasive pulmonary adenocarcinoma: A proposal from the international association for the study of lung cancer pathology committee. J Thorac Oncol. 2020;15(10):1599\u2013610. https:\/\/doi.org\/10.1016\/j.jtho.2020.06.001. PMID 32562873.","journal-title":"J Thorac Oncol"},{"key":"2725_CR24","doi-asserted-by":"publisher","unstructured":"Ruffini E, Asioli S, Filosso PL, Buffoni L, Bruna MC, Mossetti C, et al.. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?. J Thorac Oncol. 2011;6(2):319\u201326.\u00a0\u00a0https:\/\/doi.org\/10.1097\/JTO.0b013e3182011f70, 7th ed. PMID 21164365.","DOI":"10.1097\/JTO.0b013e3182011f70"},{"issue":"5","key":"2725_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2022.02.005","volume":"17","author":"R Fujikawa","year":"2022","unstructured":"Fujikawa R, Muraoka Y, Kashima J, Yoshida Y, Ito K, Watanabe H, et al. Clinicopathologic and genotypic features of lung adenocarcinoma characterized by the International Association for the Study of Lung Cancer grading system. J Thorac Oncol. 2022;17(5):700\u20137. https:\/\/doi.org\/10.1016\/j.jtho.2022.02.005. PMID 35227909.","journal-title":"J Thorac Oncol"},{"key":"2725_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lungcan.2022.07.003","volume":"170","author":"B Ahn","year":"2022","unstructured":"Ahn B, Yoon S, Kim D, Chun SM, Lee G, Kim HR, et al. Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma. Lung Cancer. 2022;170:176\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2022.07.003. PMID 35820357.","journal-title":"Lung Cancer"},{"key":"2725_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2015.11.012","volume":"91","author":"K Saruwatari","year":"2016","unstructured":"Saruwatari K, Ikemura S, Sekihara K, Kuwata T, Fujii S, Umemura S, et al. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations. Lung Cancer. 2016;91:7\u201314. https:\/\/doi.org\/10.1016\/j.lungcan.2015.11.012. PMID 26711928.","journal-title":"Lung Cancer"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02725-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:05:23Z","timestamp":1730419523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02725-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3146056\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Fujian Medical University Union Hospital (No. 2022KY006). The requirement for informed consent was waived by the Ethics Committee of Fujian Medical University Union Hospital due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}